Brand / product

ABEVMY

Bevacizumab · 100 mg/4 mL

Current listed pricePKR 25,715.62Effective 2026-07-23

Product details

Generic: Bevacizumab
Therapeutic class: —
ATC: —
Strength: 100 mg/4 mL
Dosage form: Concentrate for solution for infusion
Pack: 1's
Registration no.: 107907
Verification: 2026-08-08

Manufacturer

AGP Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

Traceability

Official price history

Amount	Effective from	Verified	Source	Status
PKR 25,715.62	2026-07-23	2026-08-08	DRAP PharmaPrice Index	Current

Same generic

Alternative listed brands

Abevmy 400 400 mg/16 mL (25 mg/mL)AGP Limited · PKR 102,238.25 Avastin 400 mg/16 mLRoche Pakistan Ltd · PKR 236,486.52 Avastin 100 mg/4 mLRoche Pakistan Ltd · PKR 59,483.08 Bevec 400 mg/16 mL (25 mg/mL)PHARMEVO (PVT) LTD. · PKR 102,238.25 Bevec 100 mg/4 mL (25 mg/mL)PHARMEVO (PVT) LTD. · PKR 25,715.63 Cizumab 400 mg/16 mLThe Searle Company Limited · PKR 132,267.99 Cizumab 100 mg/4 mLThe Searle Company Limited · PKR 33,268.91 Cizumab EU 400 mg/16 mLThe Searle Company Limited · PKR 102,238.25

Price note: MedInfoBase displays source-listed prices where available. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.